TNFSF10 and neoplasm: To circumvent the resistance to TRAIL, treatment strategies combining TRAIL with anti-cancer drugs have been designed where a synergistic increase in tumour cell apoptosis is seen that can be attributed to the activation of pro-apoptotic and the de-activation of pro-survival genes10–13.